Abstract
Purpose : To report a case of vitelliform macular dystrophy treated by intavitreal bevacizumab for choroidal neovascularization. Case : A 23-year-old female presented with suddenly impaired vision in her right eye. She had been diagnosed with vitelliform macular dystrophy when seen by an ophthalmologist for ocular trauma 8 years before. Findings : Corrected visual acuity was 0.5 right and 1.2 left. The right eye showed subretinal hemorrhage in the macular area. Fluorescein angiography showed findings suggestive of choroidal neovascularization in the macula. The right eye was treated by two sessions of intravireal bevacizumab at a 4-week interval. Visual acuity in the right eye improved to 1.0 3 months later. She has been doing well for 6 months until present. Conclusion : This case illustrates that intravitreal bevacizumab may be effective for choroidal neovascularization secondary to vitelliform macular dystrophy.
| Original language | English |
|---|---|
| Pages (from-to) | 1063-1067 |
| Number of pages | 5 |
| Journal | Japanese Journal of Clinical Ophthalmology |
| Volume | 66 |
| Issue number | 7 |
| Publication status | Published - Jul 2012 |
All Science Journal Classification (ASJC) codes
- Ophthalmology